A detailed history of Highview Capital Management LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Highview Capital Management LLC holds 5,669 shares of VRTX stock, worth $2.84 Million. This represents 1.09% of its overall portfolio holdings.

Number of Shares
5,669
Previous 5,535 2.42%
Holding current value
$2.84 Million
Previous $2.59 Million 1.62%
% of portfolio
1.09%
Previous 1.09%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$460.0 - $505.78 $61,640 - $67,774
134 Added 2.42%
5,669 $2.64 Million
Q2 2024

Jul 29, 2024

BUY
$392.81 - $485.53 $43,209 - $53,408
110 Added 2.03%
5,535 $2.59 Million
Q1 2024

Apr 26, 2024

BUY
$407.69 - $446.08 $141,060 - $154,343
346 Added 6.81%
5,425 $2.27 Million
Q4 2023

Jan 29, 2024

BUY
$343.0 - $410.68 $41,503 - $49,692
121 Added 2.44%
5,079 $2.07 Million
Q3 2023

Oct 20, 2023

SELL
$338.18 - $362.46 $2,367 - $2,537
-7 Reduced 0.14%
4,958 $1.72 Million
Q2 2023

Jul 19, 2023

BUY
$314.42 - $351.91 $75,146 - $84,106
239 Added 5.06%
4,965 $1.75 Million
Q1 2023

Apr 26, 2023

BUY
$283.23 - $323.1 $7,363 - $8,400
26 Added 0.55%
4,726 $1.49 Million
Q4 2022

Jan 30, 2023

BUY
$285.76 - $321.48 $15,431 - $17,359
54 Added 1.16%
4,700 $1.36 Million
Q3 2022

Nov 01, 2022

BUY
$273.83 - $305.53 $1.27 Million - $1.42 Million
4,646 New
4,646 $1.35 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Highview Capital Management LLC Portfolio

Follow Highview Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Highview Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Highview Capital Management LLC with notifications on news.